Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stomach cancer
Pharma
AstraZeneca says Imfinzi keeps stomach cancer from coming back
Imfinzi is the first immunotherapy to significantly improve event-free survival in a phase 3 trial in resectable early-stage stomach cancer.
Angus Liu
Mar 7, 2025 9:48am
AZ, Daiichi's Enhertu delivers survival win in stomach cancer
Mar 3, 2025 3:43pm
Merck, Eisai combo misses survival goal in GI cancer trial
Jan 24, 2025 10:26am
Experts back FDA's plan to restrict PD-1 drugs in GI cancers
Sep 26, 2024 1:38pm
FDA challenges broad use of PD-1 drugs in stomach cancer
Sep 24, 2024 2:30pm
Eli Lilly partner Hutchmed scraps stomach cancer filing
Aug 30, 2024 10:39am
